Royal Bank of Canada »

Eagle Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $18k 3.6k 4.93
2023-09-30 $37k 1.9k 20.00
2023-06-30 $70k 3.5k 20.00
2022-12-31 $86k 2.9k 29.31
2022-09-30 $88k 3.3k 26.40
2021-06-30 $233k 5.8k 40.00
2021-03-31 $318k 7.6k 41.92
2020-12-31 $486k 10k 46.62
2020-09-30 $448k 11k 42.40
2020-06-30 $364k 7.6k 47.90
2020-03-31 $376k 8.2k 45.89
2019-12-31 $1.3M 21k 60.07
2019-09-30 $1.1M 19k 56.58
2019-03-31 $682k 14k 49.82
2018-12-31 $26k 638 40.75
2018-09-30 $51k 720 70.18
2018-06-30 $50k 663 75.41
2018-03-31 $301k 5.7k 52.79
2017-12-31 $2.0M 37k 53.44
2016-12-31 $317k 4.0k 78.26
2016-09-30 $0 14k 0.00
2016-06-30 $479k 12k 38.78
2016-03-31 $484k 12k 40.52
2015-12-31 $644k 7.3k 88.66
2015-09-30 $183k 2.5k 73.24
2015-03-31 $21k 500 42.00
2014-12-31 $8.0k 500 16.00
2014-09-30 $4.0k 300 13.33
2014-06-30 $4.0k 300 13.33
2014-03-31 $4.0k 300 13.33